基于个体化概率方法的卵巢癌诊断
研究采用质谱分析来自四个地理位置的431例卵巢癌患者和133例正常女性的血清样本,通过递归特征消除与重复交叉验证筛选代谢物并构建共识分类器。该模型区分癌症与对照样本的准确率为93%,并据此开发了分配个体患癌概率的临床工具。作者认为这种个体化概率诊断方法比传统二元检测更具临床信息价值。
要点
- 基于血清代谢谱的机器学习分类器区分卵巢癌与正常样本的准确率为93%。
- 模型输出的个体概率被转化为分配患癌可能性的临床工具。
- 作者认为个体化概率诊断比传统二元检测更具临床信息价值且更准确。
核心结论
- 采用代谢组学图谱与机器学习分类器的整合方法开发了分配个体患卵巢癌概率的临床工具。
- 这种个体化概率诊断方法比传统二元(是/否)检测更具临床信息价值且更准确,代表卵巢癌早期检测的有前景的新方向。
研究设计与样本
- 研究分析了来自四个地理位置的431例卵巢癌患者和133例正常女性的血清样本,采用质谱法检测。
- 使用递归特征消除结合重复交叉验证识别可靠代谢物,并开发区分癌症与非癌症的共识分类器。
主要发现
- 共识分类模型区分癌症与对照样本的准确率为93%。
- 个体患者评分的频率分布被用于开发分配个体患癌或未患癌可能性的临床工具。
临床怎么用
- 作者认为这种个体化概率诊断方法比传统二元检测更具临床信息价值且更准确,代表卵巢癌早期检测的有前景的新方向。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The identification/development of a machine learning-based classifier that utilizes metabolic profiles of serum samples to accurately identify individuals with ovarian cancer. METHODS: Serum samples collected from 431 ovarian cancer patients and 133 normal women at four geographic locations were analyzed by mass spectrometry. Reliable metabolites were identified using recursive feature elimination coupled with repeated cross-validation and used to develop a consensus classifier able to distinguish cancer from non-cancer. The probabilities assigned to individuals by the model were used to create a clinical tool that assigns a likelihood that an individual patient sample is cancer or normal. RESULTS: Our consensus classification model is able to distinguish cancer from control samples with 93% accuracy. The frequency distribution of individual patient scores was used to develop a clinical tool that assigns a likelihood that an individual patient does or does not have cancer. CONCLUSIONS: An integrative approach using metabolomic profiles and machine learning-based classifiers has been employed to develop a clinical tool that assigns a probability that an individual patient does or does not have ovarian cancer. This personalized/probabilistic approach to cancer diagnostics is more clinically informative and accurate than traditional binary (yes/no) tests and represents a promising new direction in the early detection of ovarian cancer.
引用
- Ban D, Housley SN, Matyunina LV, et al. A personalized probabilistic approach to ovarian cancer diagnostics. Gynecol Oncol. 2024. PMID: 38266403. doi:10.1016/j.ygyno.2023.12.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。